Skip to main content
. 2000 Sep;157(3):787–794. doi: 10.1016/s0002-9440(10)64592-0

Figure 3.

Figure 3.

Cyclin E immunostaining and prognosis. The curves show the associations of cyclin E expression with tumor-specific survival in all stages (A), recurrences in pTa tumors (B), progression in pT1 carcinomas (C), and tumor-specific survival in pT2–4 TCC (D).